ASIA EUROPEAN HEMP (AEHA) ALLIANCE

The Asia European Hemp Alliance (AEHA) was founded by a team with over years of experience rooted in the pharmaceutical sector and publicly listed companies. Our mission is to accelerate sustainable growth across Europe and Asia by unlocking the full potential of hemp and cannabinoid innovation for the benefit of society, science, and industry. AEHA began with a focus on hemp seed oil and industrial hemp, areas supported by strong clinical research and real-world applications. This foundation enabled early strategic partnerships and deep operational insight across markets. In 2022, in response to the global surge in legal medical cannabis and CBD adoption, AEHA launched three dedicated divisions across Europe, the United Kingdom, and Asia. These divisions support the development and oversight of a premium range of CBD-based oils, balms, and wellness products, all under full brand ownership. With the support of clinical stakeholders, our European and UK divisions have gathered anonymized patient use data, revealing evolving preferences and prescription patterns. These insights now inform our efforts to deliver responsible innovation and support therapeutic pathways in Asian markets, backed by science and ethics. AEHA proudly engages with embassies, NGOs, and community organizations working in the fields of industrial hemp, CBD education, and legally prescribed medical cannabis. We advocate for a science-based, policy-aligned, and globally cooperative approach to the hemp and cannabinoid sectors. Disclaimer: AEHA is an independent industry alliance. We do not sell, prescribe, or distribute any controlled substances. All information shared is intended for educational, scientific, and collaborative purposes, and complies with all applicable legal frameworks. Sincerely, The Founding Team Asia European Hemp Alliance (AEHA).